Posts

Showing posts with the label mortality

statin use after breast cancer dec mortality

  a recent article found that in patients with early breast cancer, statin use after the diagnosis of breast cancer was associated with lower all-cause and breast cancer-specific mortality particularly among patients with hormone receptor-positive subtypes: see breast cancer statin use helps JAMAonc2026 in dropbox, or doi:10.1001/jamanetworkopen.2026.16375 Details : -- 7389 female patients with early invasive breast cancer (BC) in Finland were included in this retrospective population-based cohort study,  based on the Finnish national registries from 1995 and 2013     -- 2313 who were on statins after their BC diagnosis and outcomes were compared to 5076 who were not on statins -- patient characteristics, comparing the groups with breast cancer diagnosis who were on statins after BC diagnosis vs those women having no statins after BC diagnosis:     -- median age: 64 vs 58 yo     -- median follow-up time: 7.4 vs 6.0 years     -- deaths: ...

metformin seems okay in patients with severe kidney disease

Image
  a recent Scottish study found that patients with diabetes who develop stage 4 chronic kidney disease (CKD) and continue metformin had improved survival (see dm metformin with lower GFR AmJKidnDis2025  in dropbox, or doi: 10.1053/ j.ajkd.2024.08.012) Details : -- 371,742 Scottish residents with type 2 diabetes were evaluated from the Scottish Diabetes Research Network-National Diabetes Study, from 2010-2019 -- 4,287 prevalent metformin users were identified who had incident stage 4 CKD (ie, eGFR <30); 1,713 of them (40.1%) discontinued the metformin     -- patients who stopped the metformin did so within 6 months of reaching CKD stage 4; those who continued metformin did so for at least 6 months     --55% of those who continued the metformin did stop it in the follow-up period (about 60 patients/year from years 7-12, about 25/year from year 13 to end of study): 44% continued throughout the follow-up -- median age 77, 51% women...

mortality benefits from decreasing wealth inequity in the US

  A recent analysis found that wealth redistribution to decrease inequities in the United States would be predicted to lead to both substantial reductions in social inequities together with population longevity, similar to other high income countries in the world (see  income inequality dec life expectancy JAMAIntMed2024  in dropbox or d oi:10.1001/jamainternmed.2023.7975)   Details : -- 35,164 participants were evaluated with data on wealth and longevity from the Health and Retirement Study (1992-2018), a study of community-dwelling individuals >50yo, assessing the difference between personal wealth and their death rates. Death rates were adjudicated through the National Death Index     -- the HRS involved interviews in 14 biennial waves     -- the researchers chose to assess deciles of wealth given the nonlinear pattern of wealth differences in the US (see below for details of the dramatic inequities within the US)   ...